The study of effectiveness of platelet-rich plasma (PRP) treatment for lichen planus pigmentosus (pilot study)

Institute of dermatology0 个研究点目标入组 15 人开始时间: 2023年2月2日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Patients who were diagnosed with lichen planus pigmentosus, age 18 - 60 years
•2. Has facial LPP lesion for at least 6 months
•3. Histology confirmed LPP as evidenced by perivascular infiltrate, lichenoid reaction, melanophages and pigment pigmentation (melanin) accumulates under the epidermis and dermis.
•4. Patch test result is negative

•1. Patients who are pregnant or breastfeeding
•2. Patients with a history of keloids, hypertrophic scars, herpes virus infection or skin disease around the lesion
•3. Patients with blood disorders, liver disease or patients receiving chemotherapy/ anticoagulants
•4. Patients with hyperpigmentation from other conditions, such as pigmented contact dermatitis, with positive patch test results, fixed drug eruption, lichenoid drug reaction, ochronosis, melasma, PIH, endocrinopathies, etc.
•5. Patients with a history of treatment using topical bleaching agents and lasers within 6 months prior to study participation.

发起方

Institute of dermatology